134 related articles for article (PubMed ID: 35725312)
1. [Expression of pepsin in nasopharyngeal carcinoma and its correlation with quality of life after radiotherapy].
Zhang T; Yu GD; Jin FW; Zhou J; Tang ZP; Xian ZM; Wu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):699-705. PubMed ID: 35725312
[No Abstract] [Full Text] [Related]
2. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
Liu YP; Lv X; Zou X; Hua YJ; You R; Yang Q; Xia L; Guo SY; Hu W; Zhang MX; Chen SY; Lin M; Xie YL; Liu LZ; Sun R; Huang PY; Fan W; Guo X; Hong MH; Chen MY
Cancer Commun (Lond); 2019 Nov; 39(1):75. PubMed ID: 31730020
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux.
Na SY; Kwon OE; Lee YC; Eun YG
Laryngoscope; 2016 Dec; 126(12):2770-2773. PubMed ID: 27075393
[TBL] [Abstract][Full Text] [Related]
4. Association Between Pepsin in the Saliva and the Subjective Symptoms in Patients With Laryngopharyngeal Reflux.
Jung AR; Kwon OE; Park JM; Dong SH; Jung SY; Lee YC; Eun YG
J Voice; 2019 Mar; 33(2):150-154. PubMed ID: 29174850
[TBL] [Abstract][Full Text] [Related]
5. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
Chen J; Liu P; Wang Q; Wu L; Zhang X
Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
[TBL] [Abstract][Full Text] [Related]
6. Correlation between IL-17A expression in nasopharyngeal carcinoma tissues and cells and pathogenesis of NPC in endemic areas.
Wang LX; Ma RX; Di LL; Peng XB; Kang ZP; Zhong S
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3131-3138. PubMed ID: 31456038
[TBL] [Abstract][Full Text] [Related]
7. Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy.
Lan X; Chan JYK; Pu JJ; Qiao W; Pang S; Yang WF; Wong KCW; Kwong DLW; Su YX
Radiother Oncol; 2020 Sep; 150():97-103. PubMed ID: 32544605
[TBL] [Abstract][Full Text] [Related]
8. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes.
Bobin F; Journe F; Lechien JR
Laryngoscope; 2020 May; 130(5):1278-1281. PubMed ID: 31461170
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
[TBL] [Abstract][Full Text] [Related]
11. Impact of changes in psychological resilience during treatment with intensity-modulated radiotherapy on nasopharyngeal carcinoma patients: a prospective study.
Lu N; Qin T; Hu W
Ann Palliat Med; 2022 Jan; 11(1):123-134. PubMed ID: 35144404
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
14. Delayed Sino-nasal Complications of Radiotherapy for Nasopharyngeal Carcinoma.
Alon EE; Lipschitz N; Bedrin L; Gluck I; Talmi Y; Wolf M; Yakirevitch A
Otolaryngol Head Neck Surg; 2014 Aug; 151(2):354-8. PubMed ID: 24732689
[TBL] [Abstract][Full Text] [Related]
15. [Research of SIRT1 on promoting the proliferation, migration and lipid metabolism of nasopharyngeal carcinoma].
Yin HM; He X; Shan Y; Zhai HX; Zhang KW; Xia T; Zhang SY; Chen WH; You YW
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):934-943. PubMed ID: 33036508
[No Abstract] [Full Text] [Related]
16. Presence of pepsin in laryngeal tissue and saliva in benign and malignant neoplasms.
Zubčić Ž; Mendeš T; Včeva A; Mihalj H; Bogović V; Milanković SG
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33103719
[TBL] [Abstract][Full Text] [Related]
17. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study.
Sereg-Bahar M; Jerin A; Jansa R; Stabuc B; Hocevar-Boltezar I
Clin Otolaryngol; 2015 Jun; 40(3):234-9. PubMed ID: 25516364
[TBL] [Abstract][Full Text] [Related]
18. Does Pepsin Saliva Concentration (Peptest™) Predict the Therapeutic Response of Laryngopharyngeal Reflux Patients?
Lechien JR; Bobin F; Dequanter D; Rodriguez A; Le Bon S; Horoi M; Thill MP; Salem C; Muls V; Saussez S
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):996-1003. PubMed ID: 33467863
[TBL] [Abstract][Full Text] [Related]
19. [Changes of caries activity and calcium, phosphorus concentrations in saliva of patients with nasopharyngeal carcinoma before and after radiotherapy].
Liu H; Que G; Zou L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):53-6. PubMed ID: 23484303
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
